Carregant...

CDK4/6 and MAPK—Crosstalk as Opportunity for Cancer Treatment

Despite the development of targeted therapies and novel inhibitors, cancer remains an undefeated disease. Resistance mechanisms arise quickly and alternative treatment options are urgently required, which may be partially met by drug combinations. Protein kinases as signaling switchboards are freque...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Pharmaceuticals (Basel)
Autors principals: Scheiblecker, Lisa, Kollmann, Karoline, Sexl, Veronika
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2020
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7760252/
https://ncbi.nlm.nih.gov/pubmed/33255177
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph13120418
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!